文献速递神经肌肉病认知障碍与痴呆

无症状C9orf72突变携带者的纵向磁共振成像可区分向肌萎缩侧索硬化或肌萎缩侧索硬化伴额颞叶痴呆的临床转化者

Longitudinal Magnetic Resonance Imaging in Asymptomatic C9orf72 Mutation Carriers Distinguishes Phenoconverters to Amyotrophic Lateral Sclerosis or Amyotrophic Lateral Sclerosis With Frontotemporal Dementia.
PubMed 文献 · Ann Neurol · 2024-11-02

研究前瞻性纳入56名无症状C9orf72突变携带者、132名非携带者及359名人群对照,纵向测量皮层厚度、脑回化及皮层下体积。5名携带者转化为ALS或ALS-FTD,症状出现前6年即见额颞顶扣带回皮层及丘脑、海马、杏仁核萎缩;联合基线与随访相似度或可作为识别风险的影像标志物。

要点

  • C9orf72突变携带者症状前6年即可见额颞顶扣带回皮层及皮层下萎缩。
  • 采用DSC与KLS相似度可识别接近临床转化者萎缩模式的携带者。
  • 预测80岁时27.9%(95%CI 13.2-40.1%)的C9orf72携带者达到转化者DSC水平,非携带者为0。

核心结论

  • 临床转化者症状出现前数年即可见特征性萎缩模式,联合基线与随访相似度或可作为识别ALS或ALS-FTD风险的影像标志物。

研究设计与样本

  • 前瞻性研究纳入56名无症状C9orf72突变携带者、132名非携带者及359名人群对照,用3T磁共振纵向测量皮层厚度、脑回化及皮层下体积。
  • 以未转化携带者107次扫描建立参考并个体化萎缩模式,以症状前转化者10次扫描为模板进行组间比较与相似度评估。

主要发现

  • 5名无症状C9orf72突变携带者转化为ALS或ALS-FTD。
  • 转化者症状出现前至多6年即见额叶、颞叶、顶叶及扣带回皮层显著萎缩,丘脑、海马及杏仁核体积较其他C9orf72携带者更小。
  • 部分未转化携带者DSC与KLS较高、接近转化者,其余携带者及非携带者与对照较低。
  • 预测80岁时27.9%(95%CI 13.2-40.1%)的C9orf72携带者达到转化者DSC水平,非携带者为0。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We prospectively studied asymptomatic C9orf72 mutation carriers, identifying those developing amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD). METHODS: We enrolled 56 asymptomatic family members (AFM) with a C9orf72 mutation (AFM C9+), 132 non-carriers (AFM C9-), and 359 population-based controls. Using 3 T magnetic resonance imaging, we measured cortical thickness, gyrification, and subcortical volumes longitudinally. Linear mixed-effects models on non-converting AFM C9+ scans (n = 107) created a reference for these measurements, establishing individual atrophy patterns. Atrophy patterns from presymptomatic phenoconverters (n = 10 scans) served as a template for group comparisons and similarity assessments. Similarity with phenoconverters was quantified using Dice similarity coefficient (DSC) for cortical and Kullback-Leibler similarity (KLS) for subcortical measures. Using longitudinal similarity assessments, we predicted when participants would reach the average similarity level of phenoconverters at their first post-onset scan. RESULTS: Five AFM C9+ converted to ALS or ALS-FTD. Up to 6 years before symptoms, these phenoconverters exhibited significant atrophy in frontal, temporal, parietal, and cingulate cortex, along with smaller thalamus, hippocampus, and amygdala compared to other AFM C9+. Some non-converted AFM C9+ had high DSC and KLS, approaching values of phenoconverters, whereas others, along with AFM C9- and controls, had lower values. At age 80, we predicted 27.9% (95% confidence interval, 13.2-40.1%) of AFM C9+ and no AFM C9- would reach the same DSC as phenoconverters. INTERPRETATION: Distinctive atrophy patterns are visible years before symptom onset on presymptomatic scans of phenoconverters. Combining baseline and follow-up similarity measures may serve as a promising imaging biomarker for identifying those at risk of ALS or ALS-FTD. ANN NEUROL 2025;97:281-295.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. van Veenhuijzen K, Tan HHG, Nitert AD, et al. Longitudinal Magnetic Resonance Imaging in Asymptomatic C9orf72 Mutation Carriers Distinguishes Phenoconverters to Amyotrophic Lateral Sclerosis or Amyotrophic Lateral Sclerosis With Frontotemporal Dementia. Ann Neurol. 2024. PMID: 39487710. doi:10.1002/ana.27116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。